Otsuka Holdings Co., Ltd.

Pharmaceuticals
Japan
Earnings Per Share Growth (%)N/A
Cost of Goods Sold (US$ Millions)$3,732
Current Liabilities (US$ Millions)$3,880
Total Assets (US$ Millions)$9,776
Long Term Debt$1,990
Return on EquityN/A
Revenue (US$ Millions)$12,006
Total Company Assets$21,004
Revenue Growth (%)N/A
Net Income (US$ Millions)$699
Earnings Per Share (US$)N/A
Total Equity (US$ Millions)$13,746
Profit Margin (%)5.82%
Debt To Equity Ratio (%)0.14%
Inventory Turnover$1,204